Systematic review study protocol of literature from 2018 to end of 2022 of stated preference studies about HIV care and prevention services around the world

Author:

Block Ngaybe Maiya GORCID,Ravi Priyanka,Rosales Arturo,Camarena Jose L,Madhivanan Purnima

Abstract

BackgroundThere are currently over 38 million individuals around the globe living with the HIV and AIDS. As many HIV prevention and care services emerging for public use services become available to a wider audience, there is a growing need for more information about willingness to engage in these care and services. Stated preference research methods have been shown to be useful methods to help predict factors that influence health behaviours in the future.Research questionThis is a systematic review of findings from stated preference studies regarding the choices of people living with HIV or people at risk of contracting HIV to engage in HIV prevention or care.MethodsOur team plans to compile stated preference studies studying the choice to engage in HIV prevention or care services. Studies will be included from 1 January 2018 until 28 October 2022. There will be no restrictions on the language or location of the study. We will search databases including PubMed, PsycINFO, Embase, Scopus, Tufts CEA registry and CINAHL. Two researchers will review each article’s title, abstract, then full-text and finally extract relevant data based on a predetermined process. Data will be presented in a narrative review and in an exploratory meta-analysis by subgroups of studies.Ethics and dissemination of researchThere is no need for an ethical review process of this study since all data used is available publicly. The findings of this study will be reported in relevant conferences and submitted for publication in a peer-reviewed journal.PROSPERO registration numberCRD42023397785.

Publisher

BMJ

Reference24 articles.

1. UNAIDS . Global HIV & AIDS Statistics - fact sheet; Available: https://www.unaids.org/en/resources/fact-sheet

2. HIV.gov . Long-acting HIV prevention tools. 2022. Available: https://www.hiv.gov/hiv-basics/hiv-prevention/potential-future-options/long-acting-prep

3. Food and Drug Administration . FDA APPROVES first Injectable treatment for HIV pre-exposure prevention [press release]; 2021.

4. Stated-preference research in HIV: a scoping review;Humphrey;PLoS One,2019

5. National Institute of Allergy and Infectious Diseases . History of HIV vaccine research; 2018. Available: https://www.niaid.nih.gov/diseases-conditions/hiv-vaccine-research-history

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3